Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system

被引:27
|
作者
Lee, Sanghoon [1 ]
Kim, Dong Wook [2 ]
Kwon, Sunmo [2 ]
Kim, Hyung Jun [2 ]
Cha, In-Ho [2 ]
Nam, Woong [1 ,2 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Oral Oncol Clin, 323 Ilsan Ro, Goyang Si 10408, Gyeonggi Do, South Korea
[2] Yonsei Univ, Coll Dent, Dept Oral & Maxillofacial Surg, 50-1 Yonsei Ro, Seoul 03722, South Korea
关键词
TO-LYMPHOCYTE RATIO; SQUAMOUS-CELL CARCINOMA; POOR-PROGNOSIS; MONOCYTE COUNT; SURVIVAL; NEUTROPHILS; PLATELET; PREDICTS; SCORE; HEAD;
D O I
10.1038/s41598-020-68991-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been recognized that systemic inflammatory markers (SIMs) are associated with patient survival in various types of cancer. This study aimed to determine the optimal cut-off values, and to evaluate the prognostic performance of SIMs for oral squamous cell carcinoma (OSCC) within the framework of the American Joint Committee of Cancer (AJCC) cancer staging manual, 8th edition. Records were collected for a total 291 patients who had had a peripheral blood test within 1 week prior to surgery and had undergone the surgical resection of OSCC in a single institution between 2005 and 2018. The cut-off values of SIMs were obtained, and the survival analyses for overall survival (OS) and disease-free survival (DFS) were performed. Multivariate analyses incorporating other clinicopathologic factors were performed to verify the independent risk factors for survival. The cut-off values of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were 2.23, 135.14 for OS and 2.16, 131.07 for DFS, respectively, demonstrating a significant association for OS and DFS in OSCC. AJCC pathologic regional lymph node category (pN) (P<0.001), perineural invasion (PNI) (P<0.001) and NLR (P<0.001) were independent predictors for OS. Meanwhile, for DFS, AJCC pN (P=0.018) and NLR (P=0.015) were shown to be independent predictors. Before the curative surgery, NLR and PLR could be auxiliary parameters for OS and DFS in OSCC. And based on the 8th edition of AJCC staging system, elevated NLR will be a potential indicator of the worse OS or DFS along with pN or PNI in OSCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Comparison of Prognostic Performance of 8th and 7th Edition of AJCC Staging System for Patients With Gallbladder Cancer Undergoing Curative Intent Surgery
    Gupta, Sameer
    Verma, Abhishek
    Chaturvedi, Arun
    Prakash, Puneet
    Kumar, Vijay
    Misra, Sanjeev
    Akhtar, Naseem
    Rajan, Shiv
    Agarwal, Preeti
    Smith, Lynette
    Schissel, Makayla
    Are, Chandrakanth
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [42] 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers
    Chun, Yun Shin
    Pawlik, Timothy M.
    Vauthey, Jean-Nicolas
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 845 - 847
  • [43] AJCC 8th Edition: Colorectal Cancer
    Weiser, Martin R.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1454 - 1455
  • [44] AJCC 8th Edition: Colorectal Cancer
    Martin R. Weiser
    Annals of Surgical Oncology, 2018, 25 : 1454 - 1455
  • [45] Validation of the prognostic value of 8th edition revisions of the AJCC staging system for non-small cell lung cancer: A SEER database analysis
    Abdel-Rahman, O.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01)
    Krecko, Laura K.
    Neuman, Heather B.
    Greenberg, Caprice C.
    Wilke, Lee G.
    Hanlon, Bret M.
    Edge, Stephen B.
    Ruddy, Kathryn J.
    Partridge, Ann H.
    Le-Rademacher, Jennifer
    Yang, Dou-Yan
    Havlena, Jeffrey
    R. Schumacher, Jessica
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5880 - 5887
  • [47] Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers
    Cheng, Zhangjun
    Lei, Zhengqing
    Si, Anfeng
    Yang, Pinghua
    Luo, Tao
    Guo, Guangmeng
    Zhou, Jiahua
    Wang, Xuan
    Li, Zheng
    Xia, Yong
    Li, Jun
    Wang, Kui
    Yan, Zhenlin
    Wei, Wenxin
    Hartmann, Daniel
    Hueser, Norbert
    Lau, Wan Y.
    Shen, Feng
    HPB, 2019, 21 (12) : 1656 - 1666
  • [48] Molecular validation of the 8th edition AJCC cancer staging system in patients with resected pancreatic cancer: Proposal of integrative translational staging system.
    Lee, Sung Hwan
    Lee, Sunyoung S.
    Lee, Ju-Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
    Chun, Yoon Hee
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Kim, Beom Kyung
    Choi, Gi Hong
    Kim, Kyung Sik
    Choi, Jin Sub
    Ahn, Sang Hoon
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (17) : 2568 - 2575
  • [50] The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis
    Liu, Jiu-Yang
    Peng, Chun-Wei
    Yang, Xiao-Jun
    Huang, Chao-Qun
    Li, Yan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (01): : 292 - 303